Hepatocellular carcinoma (HCC) is the fifth most common malignancy caused by environmental and genetic factors. MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions. They participate in diverse biological pathways and function as gene regulators. Genetic polymorphisms in 3# untranslated regions (3# UTRs) targeted by miRNAs alter the strength of miRNA binding, with consequences on regulation of target genes thereby affecting the individual's cancer risk. We have previously predicted polymorphisms falling in miRNA-binding regions of cancer genes. We selected an insertion/deletion (Indel) polymorphism (rs3783553) in the 3# UTR of interleukin (IL)-1a (IL1A) for a case-control study in a Chinese population. With samples from 403 HCC patients and 434 healthy control individuals, strong evidence of association was observed for the variant homozygote. This association was validated in a second independent case-control study with 1074 HCC patients and 1239 healthy control individuals (odds ratio 5 0.62; 95% confidence interval 5 0.49-0.78). We further show that the 'TTCA' insertion allele for rs3783553 disrupts a binding site for miR-122 and miR-378, thereby increasing transcription of IL-1a in vitro and in vivo. These findings suggest that functional polymorphism rs3783553 in IL1A could contribute to HCC susceptibility. Considering IL-1a affects not only various phases of the malignant process, such as carcinogenesis, tumor growth and invasiveness, but also patterns of interactions between malignant cells and the host's immune system, our results indicated that IL-1a may be a promising target for immunotherapy, early diagnosis and intervention of HCC.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy caused by environmental and genetic factors. MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions. They participate in diverse biological pathways and function as gene regulators. Genetic polymorphisms in 3# untranslated regions (3# UTRs) targeted by miRNAs alter the strength of miRNA binding, with consequences on regulation of target genes thereby affecting the individual's cancer risk. We have previously predicted polymorphisms falling in miRNA-binding regions of cancer genes. We selected an insertion/deletion (Indel) polymorphism (rs3783553) in the 3# UTR of interleukin (IL)-1a (IL1A) for a case-control study in a Chinese population. With samples from 403 HCC patients and 434 healthy control individuals, strong evidence of association was observed for the variant homozygote. This association was validated in a second independent case-control study with 1074 HCC patients and 1239 healthy control individuals (odds ratio 5 0.62; 95% confidence interval 5 0.49-0.78). We further show that the 'TTCA' insertion allele for rs3783553 disrupts a binding site for miR-122 and miR-378, thereby increasing transcription of IL-1a in vitro and in vivo. These findings suggest that functional polymorphism rs3783553 in IL1A could contribute to HCC susceptibility. Considering IL-1a affects not only various phases of the malignant process, such as carcinogenesis, tumor growth and invasiveness, but also patterns of interactions between malignant cells and the host's immune system, our results indicated that IL-1a may be a promising target for immunotherapy, early diagnosis and intervention of HCC.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer death. Because of its high fatality rates, the incidence and mortality rates are almost equal. However, of greatest importance from the public health perspective, the incidence of HCC has been rising worldwide, with particularly steep increases in Asia and Africa where hepatitis B virus (HBV) and hepatitis C virus are more prevalent (1) . Despite surgical or locoregional therapies, prognosis remains poor because of high tumor recurrence or tumor progression, and currently there are no well-established effective adjuvant therapies. Molecular biology of carcinogenesis and tumor progression of HCC has been increasingly understood with intense research in recent years. Several important intracellular signaling pathways such as the Ras/Raf/mitogen-activated protein kinase/extracellular-signal-regulated kinase pathway and phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway have been recognized, and the roles of several growth factors and angiogenic factors such as epidermal growth factor and vascular endothelial growth factor have been confirmed (2) . However, the molecular carcinogenic mechanism of HCC is still not fully understood.
MicroRNAs (miRNAs) are a class of short non-coding RNAs with posttranscriptional regulatory functions. To date, .600 human miRNAs have been experimentally identified and estimated to regulate more than one-third of cellular messenger RNAs (mRNAs). Accumulating evidence has linked the dysregulated expression patterns of miRNAs to a variety of diseases, such as cancer, neurodegenerative diseases, cardiovascular diseases and viral infections (3) (4) (5) . A growing number of evidence suggests a relationship between differential miRNA expression and HCC (6, 7) . The binding of miRNA to mRNA is critical for regulating the mRNA level and protein expression. However, this binding can be affected by polymorphisms residing in the miRNA target site, which can either abolish existing binding sites or create illegitimate binding sites (8) (9) (10) (11) . There is increasing evidence confirmed that single-nucleotide polymorphisms in 3# untranslated regions (3# UTRs) targeted by miRNAs alter the strength of miRNA binding, with consequences on regulation of target genes thereby affecting the individual's cancer risk (12) (13) (14) , Parkinson's disease (15) , drug resistance (16) and other disorders (17) (18) (19) .
Different approaches have been used to predict and identify functional polymorphisms within miRNA-binding sites (8) . Recently, we have proposed 15 putative polymorphisms falling in miRNA-binding regions of cancer genes including IL1A (20) . Molecules of the interleukin (IL)-1 family are abundant at tumor sites and they represent potent molecules that may greatly influence the direction of the malignant process. Here, we show that an indel polymorphism located within the IL1A 3# UTR significantly affects the binding of miR-122 and miR-378 and influences the regulation of IL-1a expression by these miRNAs. We found statistically significant associations between risk of HCC and variant alleles of rs3783553 (odds ratio 5 0.62; 95% confidence interval 5 0.49-0.78, for the variant homozygote) in Chinese populations. Furthermore, higher IL-1a expression was observed in tumors from patients harboring the variant allele. Our results suggest that IL-1a could be an important mediator of liver tumorigenesis. Since IL-1a affects not only various phases of the malignant process, such as carcinogenesis, tumor growth and invasiveness, but also patterns of interactions between malignant cells and the host's immune system (21, 22) , IL-1a may be a promising target for immunotherapy, early diagnosis and intervention of HCC.
Materials and methods

Study population
The case-control study was performed on genomic DNA extracted from peripheral blood of 1477 newly diagnosed incident HCC cases together with 1673 controls after obtaining informed consent. All subjects recruited were unrelated ethnic Han Chinese. For the Jiangsu's case-control study, the case series comprised 403 HCC patients diagnosed, hospitalized and treated in the affiliated hospitals of Soochow University from 1998 to 2004. For the Beijing's casecontrol study, 1074 HCC patients were recruited at the Cancer Hospital, Chinese Academy of Medical Sciences, the tertiary referral cancer center in northern China. All the patients had not been treated by any medical treatments. Patients were excluded who were suffering from: (i) autoimmune hepatitis or Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma; IL, interleukin; miRNA, microRNA; mRNA, messenger RNA; PCR, polymerase chain reaction; 3#UTR, 3#untranslated region. toxic hepatitis; (ii) primary or secondary biliary cirrhosis or Budd-Chiari syndrome; (iii) other tumors except HCC; (iv) recurrence of HCC and (v) liver disease due to parasitosis, diabetes, fatty liver, metabolism disorders and severe cardiovascular diseases. The diagnosis of these patients was confirmed by a pathological examination combined with positive imaging (Magnetic resonance imaging and/or computerized tomography). Tumor stages were determined according to a modified American Joint Committee on Cancer and international union against cancer standard. Controls were cancer-free individuals selected from a community nutritional survey that was conducted in the same regions (Jiangsu province and Beijing City) during the same period as recruitment of cancer patients and were believed to be a good representation of the population in these regions. Controls without clinical evidence of liver disease were frequency matched for age and sex to each set of HCC individuals. For Jiangsu population, each subject was personally face-to-face interviewed by trained interviewers, with a pretested questionnaire to obtain information on demographic data and related risk factors, including tobacco smoking and alcohol drinking. The subjects who smoked more than one cigarette per day for .1 year were classified as smokers. Others were defined as non-smokers. Subjects were considered as alcohol drinkers, if they drank at least once per week. All participants were negative for antibodies to hepatitis C virus, hepatitis D virus or human immunodeficiency virus. Both cases and controls had to be in good mental condition, be able to see and hear and follow an interview and (for controls) not have diagnoses clearly related to cancer or chronic inflammatory diseases. Liver tissue samples from patients with a diagnosis of HCC were collected from the affiliated hospital of Soochow University on the availability of frozen stored tissue from HCC resections from 2006 through 2008. All cases had histological confirmation of their tumor diagnosis. The response rates were 96% in the cases and 81% in the controls, respectively. The design of the study was approved by the Ethical Committee of Soochow University.
DNA extraction and genotyping
A Chelex method was used for extracting genomic DNA of blood samples (23) . As rs3783553 is a TTCA indel polymorphism, a conventional polymerase chain reaction (PCR) was performed to amplify the fragment including the single-nucleotide polymorphism with the forward primer 5#-ATTG-GTCCGATCTTTGACTC-3# and reverse primer 5#-TGATAACAGTGGT-CTCATGG-3#. The PCR products were analyzed by 7% non-denaturing polyacrylamide gel electrophoresis and visualized by silver staining (24) . The genotypes were determined by the numbers and the positions of the band on the gels. To validate the genotyping method, we analyzed 100 randomly selected DNA samples by both direct sequencing and PCR method; the concurrence rate of these two methods was 100%, suggesting that the PCR method is reliable. Genotyping was performed without knowledge of the case or control status. A 10% random sample was tested in duplicate by different persons, and the reproducibility was 100%.
IL1A 3# UTR luciferase constructs
The full-length of human IL1A 3# UTR containing TTCA allele at rs3783553 was amplified with forward primer 5#-GATCTCTAGAGTCTGGAGTCT-CACTTGTCTCACTTGTG-3# and reverse primer 5#-CATGGATCCGTCA-GAGAATTTTGTTGCAAGCTTTATTTAG -3# from a homozygous human genomic DNA sample. The PCR products were separated in agarose gel and extracted, purified and cloned with TA cloning Kit (Promega, Madison, WI). The insert containing TTCA allele was confirmed by sequencing. To obtain the same 3# UTR sequence except the different allele of rs3783553, another allele was generated with the QuickChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) with forward mutagenic deletion primer 5#-ttacctgggcattcttgtattccacctgcaatcaag-3# and a complementary reverse mutagenic deletion primer 5#-cttgattgcaggtggaatacaagaatgcccaggtaa-3# to delete TTCA. Finally, the 3# UTR of Renilla luciferase in the vector pRL-SV40 (Promega) was replaced with the full-length 3# UTR of IL1A by restriction enzymes XbaI and BamHI. The resulting constructs (pRL-IL1A-3# UTR-TTCA-allele and pRL-IL1A-3# UTR-del-allele) were verified by sequencing.
Luciferase assay HepG2 or SMMC7721 cells was maintained in Dulbecco's modified Eagle's medium with high glucose (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (Gibco) and 50 lg/ml streptomycin (Gibco) at a 37°C incubator supplemented with 5% CO 2 . Cells were seeded at 1 Â 10 5 cells per well in 24-well plates (BD Biosciences, Bedford, MA). Sixteen hours after the plating, cells were transfected by Lipofectamin 2000 according to manufacturer's suggestion. In each well, 500 ng pRL-IL1A-3# UTR vector and 50 ng pGL3 control vector were cotransfected with 0, 1, 10 and 100 pmol pre-miR-122 or pre-miR-378 (Ambion, Austin, TX) accordingly. In addition, 100 pmol Negative Control #1 from Ambion was used as negative controls in every transfection experiments. Six replicates for each group and the experiment repeated at least three times. After transfection for 24 h, cells were harvested by the addition of 100 ll passive lysis buffer. Renilla luciferase activities in cell lysate were measured with the Dual Luciferase assay system (Promega) in TD-20/20 luminometer (Turner Biosystems, Sunnyvale, CA) and were normalized with the firefly luciferase activities.
Real-time reverse transcription-PCR analysis of mRNA levels of IL-1a in different genotypic HCC liver tissues Total RNA was isolated from tumor tissue specimens with different genotypes using RNA isolation kit of Ambion and then converted to complementary DNA using an oligo(dT) 15 primer and Superscript II (Invitrogen, Carlsbad, CA). A TaqManÒ gene expression assay was performed using ABI 7300 to quantify relative IL-1a expression in these samples. The 
b-Actin was chosen as the internal control. All reactions were run in duplicate to reduce confounding variance. PCR efficiencies were calculated with a relative standard curve derived from a complementary DNA mixture (a 2-fold dilution series with seven measuring points in triplicates) and gave regression coefficients .0.95. DDCt algorithm was applied to calculate the expression levels for different groups (25) .
Statistical analysis
The genotype distribution was analyzed for Hardy-Weinberg equilibrium according to Genetic Data Analysis software, through the application of a permutation test with 3200 permutations to estimate each P value (Lewis Lab Software web site). Unconditional logistic regression was used to analyze the association between rs3783553 and cancer risk, adjusted for sex, age and HBV infection (smoking status and drinking status were adjusted for Jiangsu cohort only). As HBV infection was one of the major risk factors, a stratified analysis by HBV infection status was performed using binary logistic regression model. Student's t-test was used to examine the differences in luciferase reporter gene expression. The normalized expression values of IL-1a were compared with those of 'del/del' samples using the non-parametric Mann-Whitney U-test. These statistical analyses were implemented in Statistic Analysis System software (version 8.0, SAS Institute, Cary, NC). P ,0.05 was used as the criterion of statistical significance, and all statistical tests were two sided.
Results
Association study of rs3783553 polymorphisms with HCC
The characteristics of the 1477 HCC patients and 1673 controls included in the analysis are summarized in Table I . There were no statistically significant differences between cases and controls in terms of the frequency distribution of sex, age, smoking and drinking status (for Jiangsu cohort only). As expected, HBV infection was a significant risk factor for HCC. About 78.2% of the cases were HBsAg positive, which were significantly higher than that of the controls (8.7%, P , 0.0001). The observed genotype frequencies for rs3783553 were in agreement with that expected under the Hardy-Weinberg equilibrium in the controls (P 5 0.85). In the recessive genetic model, we found that the variant homozygote þ/þ of rs3783553 was associated with a significantly reduced risk of HCC compared with its heterozygote þ/À and homozygote À/À (odds ratio 5 0.62; 95% confidence interval 5 0.49-0.58) ( Table II) . The independent studies in Jiangsu and Beijing areas showed similar results and confirmed the association of rs3783553 polymorphisms with HCC. Given the relative large sample size, we performed stratified analysis by HBV infection status. Significant differences were seen between cases and controls after stratification (Table III , P,0.0001 for HBV positive and P 5 0.0175 for HBV negative), although Beijing population alone did not show a significant difference in the stratification analysis. The overall trend is that the differences between cases and controls were more obvious in HBV positive than the HBV negative population.
Association of rs3783553 genotypes with IL-1a mRNA expression
To further explore the effects of rs3783553 on the transcription of IL-1a, we used three different genotypic HCC liver tissue samples, 26
An indel polymorphism in the IL1A 3# UTR confers risk for HCC homozygous for the TTCA deletion allele, 25 heterozygous and 7 homozygous for the TTCA insertion allele. Taqman gene expression analysis showed that TTCA insertion homozygous group had the highest IL-1a mRNA level, followed by heterozygous and TTCA deletion group (Figure 1 ). There were 3 of 26 samples in TTCA deletion group in which their IL-1a mRNA is under the detection threshold for this method and their Ct value was conservative determined by the maximum cycle number 40. Non-parametric MannWhitney U-test of DCts of three genotypic groups showed that the P value was 0.042. Compared with TTCA deletion homozygous group, the average IL-1a expression levels of heterozygous and TTCA insertion homozygous group were 3.76-and 5.57-fold higher, respectively. Our data suggested that different genotype was associated with IL-1a mRNA expression in vivo.
rs3783553 genotypes affect IL-1a expression by regulating the miR-122 and miR-378 (in a less extent) binding in vitro Based on bioinformatics analysis, rs3783553 lies within a predicted binding site for human miR-122 (Figure 2A ) and miR-378 (not shown, outside of the seed region). Therefore, we hypothesized that miR-122 and miR-378 would bind tightly to IL-1a mRNA transcripts containing the TTCA deletion allele, negatively regulating IL-1a expression. Conversely, the binding with mRNA transcripts containing the TTCA insertion allele would be disrupted, allowing upregulated IL-1a expression.
To test this hypothesis, we replaced the 3# UTR of a Renilla luciferase reporter gene with the full-length IL1A 3# UTR containing either the TTCA deletion or the TTCA insertion alleles of rs3783553 ( Figure 2B ). In transiently transfected HepG2 cells (negative for miR-122), compared with the constructs containing TTCA insertion alleles, the translation of Renilla luciferase (representing IL-1a protein) from constructs containing the TTCA deletion allele was significantly reduced in the presence of miR-122 in a concentrationdependent manner ( Figure 2C ). Although the construct containing the insertion allele also decreased with the increasing miR-122 concentrations, a significant difference (P , 0.01) was found when the slopes of the two curves were compared, which further distinguished the magnitude of the effects of miR-122 on the transcription of different alleles ( Figure 2C ). The same experiments were repeated with another HCC cell line SMMC7721 and similar results were obtained ( Figure 2D ). This result suggests that, indeed, miR-122 binds and negatively regulates the transcription of IL-1a and that this regulation is negatively influenced by the presence of the TTCA insertion allele, presumably affecting miR-122 binding to the IL-1a transcript.
For miR-378, we observed same change pattern only when .10 pmol pre-miR-378 were added, suggesting miR-378 binding to IL-1a transcript may be less affected by rs3783553 genotypes. Thus, both in vitro and in vivo studies suggest that rs3783553 influences IL-1a expression level by alternating miR-122 and in a less extent, miR-378 targeting.
Discussion
A better understanding of distinct polymorphisms in miRNA-related gene and protein expression regulation in different diseases at the population level will be a critical step toward the clinical utilization of this new subclass of genetic variations in health management. We have identified a variant allele in the 3# UTR of IL1A that alters miR-122 and miR-378 mediated regulation of IL-1a expression and is associated with HCC risks in Chinese population. The association of this allele with HCC was identified in an eastern Chinese casecontrol study and validated in a northern Chinese case-control study, making this finding highly significant. Although the genotype frequencies are slightly different between the two populations, the difference is not statistically significant (P 5 0.6420). However, because of the lack of information on some of the HCC risk factors including drinking and smoking status for Beijing population, the results of northern Chinese case-control study were not fully justified. This could be one of the reasons that the larger population (Beijing) seems to have a weaker association with the HCC risk than the primary cohorts (Jiangsu). The stratified analysis showed that the differences between cases and controls were more obvious in HBV positive than the HBV negative population, suggesting a possible role of this polymorphism in the immune regulation during HBV infection. In the presence of HBV infection, IL-1a expression could be more critical in controlling the immune responses, therefore the function of this polymorphism exhibited in a more significant way. IL-1 is a pleiotropic cytokine that primarily affects inflammatory and immune responses, and it also regulates other homeostatic functions of the body and has important influence on the pathogenesis of disease (22) . The IL-1 gene family consists of two major agonistic molecules, namely IL-1a and IL-1b, and one antagonistic cytokine, the IL-1R antagonist (IL-1Ra). IL-1a, IL-1b and IL-1Ra are encoded by different genes. Both IL-1a and IL-1b differ from most other cytokines by lacking a signal sequence, thus not trafficking through the endoplasmic reticulum-Golgi pathway, the precise mechanisms of IL-1 secretion are thus largely unknown. Furthermore, little is known about the effects of the IL-1 molecules on the process of carcinogenesis. Results from Apte's group suggest that membraneassociated IL-1a expressed on malignant cells is immunostimulatory that stimulates antitumor immunity (22) . When expressed on tumor cells, membrane-associated IL-1a induces antitumor cell immunity that culminates in tumor regression (26) . This reconcile with our results that the risk allele (TTCA deletion) strengthens the binding of miR-122 and miR-378 with 3# UTR of IL1A which in turn inhibit the expression of IL-1a, then attenuate the antitumor immunity of this cytokine and confer risk for HCC development. On the other hand, it is also reported recently that hepatocyte necrosis triggers the release of IL-1a, which acts as a critical mediator of carcinogeninduced compensatory proliferation and HCC development, thus IL1a release by necrotic hepatocytes become an important mediator of liver tumorigenesis (27) . In this case, the level of necrosis may be more influential to tumorgenesis than the actual expression level of IL-1a. Therefore, IL-1a release could be the mediator linking chronic liver diseases to HCC, but the existing chronic liver damage is the determining factor. The mechanism supported by our results may take course in the absence of liver damages and hepatocyte An indel polymorphism in the IL1A 3# UTR confers risk for HCC necrosis. The membrane-associated IL-1a could play a different role in tumorgenesis as demonstrated by other groups from released IL1a by stimulating the antitumor immunity. MiR-122 has been shown to play an important role in the process of metastasis of HCC (28) . Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties (29) . It was demonstrated as suppressor miRNA during metastasis of HCC. Considering the low level of miR-122 at the stage of tumor metastasis, the mechanism we proposed in this paper may not play a role in that process. The risk allele generates a better binding site for mir-122 and suppresses IL-1a expression and immune surveillance, which could be more prevalent during early tumor development.
Using genetic association study, we have successfully identified the risk conferring polymorphism in the IL1A gene and a likely biological mechanism for increased risk of HCC. Given the broad effects and most abundance of miR-122 in human liver (30) , further efforts are warranted to explore whether miR-122 and IL-1a could be potentially useful for HCC diagnosis and treatment. 
